Heptane-1,3,4,5,7-pentol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Heptane-1,3,4,5,7-pentol
• 化学式: C₇H₁₆O₅
• 分子量: 180.2
• InChiKey: TVXBFESIOXBWNM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.3
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  101
• 氢给体数：
  5
• 氢受体数：
  5

文献信息

• [EN] ORGANOSILANES FOR THE TREATMENT OF INFECTIONS<br/>[FR] ORGANOSILANES POUR LE TRAITEMENT D'INFECTIONS
  申请人：TOPIKOS PHARMACEUTICALS INC

  公开号：WO2020082026A1

  公开（公告）日：2020-04-23

  Organosilicon quaternary ammonium compounds, their formulations, including lyophilized solid formulations, and methods of use to treat infections in humans and animals. New organosilane quaternary ammonium compounds are provided that are useful in pharmaceutical topical formulations to treat a range of infections, including Gram positive, Gram negative and fungal infections, in a host in need thereof.

  有机硅季铵化合物，它们的配方，包括冻干固体配方，以及使用方法，用于治疗人类和动物感染。提供了新的有机硅季铵化合物，可用于制药局部配方，以治疗宿主中需要治疗的一系列感染，包括革兰氏阳性菌、革兰氏阴性菌和真菌感染。
• PROCESS FOR PREPARING EPISULFIDE COMPOUNDS
  申请人：Asahi Kasei Chemicals Corporation

  公开号：EP2700636A1

  公开（公告）日：2014-02-26

  Provided is a method for producing an episulfide compound, the method including a step of thiating epoxy groups of (B) an epoxy compound by a reaction with (C) a thiating agent in the presence of (A) a polyhydric hydroxyl compound having two or more hydroxyl groups.

  本发明提供了一种生产环硫化化合物的方法，该方法包括以下步骤：在(A)具有两个或两个以上羟基的多羟基化合物存在下，通过与(C)硫化剂反应，硫化(B)环氧化合物的环氧基团。
• Process for Preparing Episulfide Compounds
  申请人：Nakamura Akitake

  公开号：US20140107350A1

  公开（公告）日：2014-04-17

  Provided is a method for producing an episulfide compound, the method including a step of thiating epoxy groups of (B) an epoxy compound by a reaction with (C) a thiating agent in the presence of (A) a polyhydric hydroxyl compound having two or more hydroxyl groups.
• ORGANOSILANES FOR THE TREATMENT OF INFECTIONS
  申请人：Topikos Pharmaceuticals, Inc.

  公开号：US20210253607A1

  公开（公告）日：2021-08-19

  Organosilicon quaternary ammonium compounds, their formulations, including lyophilized solid formulations, and methods of use to treat infections in humans and animals.
• US9051293B2
  申请人：——

  公开号：US9051293B2

  公开（公告）日：2015-06-09